Trials in San Diego, California
Here are the top 10 medical studies for lung cancer in San Diego, California
Popular Filters
Phase 3 Trials
Chemotherapy
Adagrasib + Pembrolizumab for Lung Cancer
Recruiting1 awardPhase 2 & 3
Rancho Mirage, California
This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.
Small Molecule Drug
Adagrasib vs Docetaxel for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Irvine, California
This trial is testing a new drug called adagrasib against an existing chemotherapy drug, docetaxel. It focuses on patients with advanced lung cancer who have a specific genetic mutation (KRAS G12C) and have already had treatment. The new drug aims to block this mutation in cancer cells to stop their growth.
Chemotherapy
Chemoradiation + Pembrolizumab/Olaparib for Small Cell Lung Cancer
Recruiting1 awardPhase 3
Loma Linda, California
This trial will compare overall survival and progression free survival of two groups of patients with advanced solid tumors - those who receive concurrent chemoradiation therapy with pembrolizumab followed by pembrolizumab plus olaparib, and those who receive concurrent chemoradiation therapy alone.
Alkylating agents
Pembrolizumab SC vs IV for Lung Cancer
Recruiting2 awardsPhase 3
Los Alamitos, California
This trial is testing a new way to give the cancer drug pembrolizumab as an injection under the skin for people with advanced lung cancer. The goal is to see if this method works as well as the traditional IV method. The study will also check if it is safe and effective when used with standard chemotherapy.
Platinum-containing Compound
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Upland, California
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Trials With No Placebo
Chemotherapy
Adagrasib + Pembrolizumab for Lung Cancer
Recruiting1 awardPhase 2 & 3
Rancho Mirage, California
This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.
Monoclonal Antibodies
Brentuximab Vedotin + Pembrolizumab for Advanced Cancers
Recruiting1 awardPhase 2
San Marcos, California
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer, including metastatic cancer that has progressed after PD-1 inhibitor treatment. The study will also find out what side effects occur.
Small Molecule
PC14586 for Solid Tumors
Recruiting1 awardPhase 1 & 2
La Jolla, California
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Alkylating agents
Pembrolizumab + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
La Jolla, California
This trial is testing pembrolizumab with or without chemotherapy to treat patients with stage IV non-small cell lung cancer that has come back and spread to other places in the body.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.